glucagon has been researched along with Cancer, Second Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hizuka, N; Kageyama, K; Moriyama, T; Sakihara, S; Suda, T; Takayasu, S; Tamasawa, N | 1 |
Brocheriou-Spelle, I; Brouland, JP; Launay, JM; Lavergne, A; Le Bodic, MF; Manivet, P; Wassef, M | 1 |
2 other study(ies) available for glucagon and Cancer, Second Primary
Article | Year |
---|---|
Hypoglycemia associated with big insulin-like growth factor II produced during development of malignant fibrous histiocytoma.
Topics: Aged; Antineoplastic Agents, Hormonal; Dexamethasone; Glucagon; Histiocytoma, Benign Fibrous; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor II; Male; Neoplasms, Second Primary; Protein Precursors; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2003 |
Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.
Topics: Adenocarcinoma; Chromogranin A; Chromogranins; Cytoplasmic Granules; Female; Glucagon; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasms, Second Primary; Neuroendocrine Tumors; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Serotonin; Somatostatin; Stomach Neoplasms | 2001 |